American Lung Association Urges New England Vaccination Push Ahead of Respiratory Virus Season
Event summary
- American Lung Association launches regional campaign to prepare New England for respiratory virus season starting October 2026.
- Region has 20% population over 65, higher than national average, increasing vulnerability to flu, COVID-19, and RSV.
- Organization recommends September-October vaccination timing for optimal immunity development.
- GSK provides support for the campaign.
The big picture
The campaign highlights New England's demographic vulnerability to respiratory illnesses, aligning with broader public health efforts to mitigate seasonal virus impacts. The American Lung Association's focus on preventive measures reflects ongoing challenges in managing aging populations and vaccine hesitancy. GSK's involvement underscores the pharmaceutical industry's role in supporting regional health initiatives.
What we're watching
- Vaccination Rates
- How New England's vaccination uptake will compare to previous years and national averages.
- Healthcare Access
- Whether insurance coverage and pharmacy availability will meet demand for vaccines.
- Seasonal Impact
- The severity of respiratory virus outbreaks and their effect on regional healthcare systems.
Related topics